Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|October 28, 2024

Key Takeaways on the Future of HER2 in NSCLC

Key Takeaways

Panelists conclude by highlighting key takeaways in the management of NSCLC.

Episodes in this series

4 KOLs are featured in this series

EP. 1 Introduction and Current Landscape of HER2 in NSCLC

4 KOLs are featured in this series

EP. 2 Safety and Efficacy of HER2-Directed ADCs for NSCLC

4 KOLs are featured in this series

EP. 3 Treatment Considerations for Patients With HER2+ NSCLC

4 KOLs are featured in this series

EP. 4 Latest Advances and Therapies for HER2+ NSCLC

4 KOLs are featured in this series

EP. 5 Unmet Needs and Clinical Considerations for HER2+ NSCLC

4 KOLs are featured in this series

EP. 6 Integrating HER2-Directed Therapies Into Standard Care for NSCLC

4 KOLs are featured in this series

EP. 7 HER2- Mutation Testing Considerations and Timing

4 KOLs are featured in this series

EP. 8 Factors Impacting Use of HER2 Therapies for NSCLC

4 KOLs are featured in this series

EP. 9 Incorporating Real-World Evidence for HER2+ NSCLC

4 KOLs are featured in this series

EP. 10 Key Takeaways on the Future of HER2 in NSCLC

4 KOLs are featured in this series

EP. 11 Real-World Outcomes in HER2-Positive NSCLC

4 KOLs are featured in this series

EP. 12 Managing Treatment Challenges in HER2-Directed Therapies

4 KOLs are featured in this series

EP. 13 Emerging Horizons in HER2-Directed NSCLC Treatments

4 KOLs are featured in this series

EP. 14 Patient Selection and Personalized Treatment Strategies

4 KOLs are featured in this series

EP. 15 Navigating Healthcare Access and Decision-Making

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

mantle cell lymphoma | Image: Perla Vicari / ASH Image Bank

Case Studies Focus on Glofitamab as Bridge to CAR T in MCL

July 20th 2026

Woman with cancer in hospital bed speaking with her male doctor about treatment | Image Credit: Rido - stock.adobe.com

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

ByBrooke McCormick

July 20th 2026

Globe and stethoscope | Image Credit: Planetz - stock.adobe.com

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise

ByBrooke McCormick

July 20th 2026

The Road Ahead: Personalized Therapy, Combination Approaches, and Key Takeaways in Extrapulmonary Neuroendocrine Carcinoma

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

July 20th 2026

Doctor holding red and yellow ribbon | Image Credit: Ekaterina - stock.adobe.com

Hepatitis Prevention Programs Improve Liver Outcomes, but Gaps in Screening, Care Remain

ByBrooke McCormick

July 19th 2026

Trending on AJMC

Medicaid MFN Pricing Could Save $8.6 Billion

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Active US Drug Shortages Rise for Third Straight Quarter

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise